Inhibikase updates presentation, highlights Phase 3 IKT-001 timelines
Inhibikase updated its corporate presentation to highlight progress on the Phase 3 IKT-001 program and anticipated clinical timelines.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.